Olfactory Bulb Signal Abnormality in Patients with COVID-19 Who Present with Neurologic Symptoms [HEAD & NECK]
CONCLUSIONS:
Olfactory bulb 3D T2 FLAIR signal intensity was greater in the patients with COVID-19 and neurologic symptoms compared with an age-matched control group with olfactory dysfunction, and this was qualitatively apparent in 4 of 12 patients with COVID-19. Analysis of these preliminary finding suggests that olfactory apparatus vulnerability to COVID-19 might be supported on conventional neuroimaging and may serve as a noninvasive biomarker of infection.
Source: American Journal of Neuroradiology - Category: Radiology Authors: Strauss, S. B., Lantos, J. E., Heier, L. A., Shatzkes, D. R., Phillips, C. D. Tags: HEAD & amp; NECK Source Type: research
More News: Brain | Coronavirus | COVID-19 | Neurology | Pandemics | Pathology | Radiology | Respiratory Medicine | SARS | Study